<!DOCTYPE html>
<html lang="en">
<head>
 <meta charset="UTF-8">
 <meta name="viewport" content="width=device-width, initial-scale=1.0">
 <title>Lesson 7: Advanced Pharmacotherapy and Nutraceutical Interactions | AccrediPro Academy</title>
 <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700;800&display=swap" rel="stylesheet">
 <style>
/* ===========================================
 ACCREDIPRO GOLD STANDARD - UNIFIED LESSON CSS v5.0
 School-Quality ‚Ä¢ ASI Certified ‚Ä¢ Premium UX
 =========================================== */

/* Reset & Base */
* {
 box-sizing: border-box;
 margin: 0;
 padding: 0;
}

body {
 font-family: 'Inter', -apple-system, BlinkMacSystemFont, sans-serif;
 line-height: 1.8;
 color: #1f2937;
 background: #ffffff;
 font-size: 17px;
}

/* MAIN WRAPPER */
.lesson-wrapper {
 max-width: 1200px;
 margin: 0 auto;
 padding: 40px 20px;
}

/* HEADER CARD - Premium Gradient */
.module-header-card {
 background: linear-gradient(135deg, #722F37 0%, #722F37 50%, #5a252b 100%);
 padding: 48px 40px;
 margin-bottom: 40px;
 border-radius: 24px;
 box-shadow: 0 20px 60px -15px rgba(114, 47, 55, 0.4);
 border: none;
 text-align: center;
 position: relative;
 overflow: hidden;
}

.module-header-card::before {
 content: '';
 position: absolute;
 top: -50%;
 left: -50%;
 width: 200%;
 height: 200%;
 background: radial-gradient(circle, rgba(255, 255, 255, 0.05) 0%, transparent 70%);
 pointer-events: none;
}

.module-label {
 font-size: 12px;
 text-transform: uppercase;
 letter-spacing: 3px;
 color: rgba(255, 255, 255, 0.8);
 margin-bottom: 12px;
 font-weight: 600;
 display: block;
}

.lesson-title {
 font-size: 38px;
 color: #ffffff;
 font-weight: 800;
 margin: 0 0 20px 0;
 line-height: 1.15;
 text-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
}

/* META BADGES */
.lesson-meta {
 display: flex;
 justify-content: center;
 gap: 12px;
 flex-wrap: wrap;
}

.meta-badge {
 background: rgba(255, 255, 255, 0.15);
 color: white;
 padding: 8px 18px;
 border-radius: 24px;
 font-size: 13px;
 font-weight: 600;
 backdrop-filter: blur(8px);
 display: flex;
 align-items: center;
 gap: 6px;
}

/* ASI CREDENTIAL STRIP */
.asi-credential-strip {
 background: linear-gradient(90deg, #f8f5f0, #fffbeb, #f8f5f0);
 border: 1px solid #e5d9c3;
 border-radius: 12px;
 padding: 16px 24px;
 margin-bottom: 32px;
 display: flex;
 align-items: center;
 gap: 16px;
}

.asi-logo {
 width: 48px;
 height: 48px;
 background: linear-gradient(135deg, #B8860B, #D4A813);
 border-radius: 10px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 24px;
 color: white;
 flex-shrink: 0;
 box-shadow: 0 4px 12px rgba(184, 134, 11, 0.25);
}

.asi-text {
 flex: 1;
}

.asi-text .label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1px;
 color: #92400e;
 font-weight: 700;
}

.asi-text .title {
 font-size: 15px;
 color: #78350f;
 font-weight: 600;
 margin-top: 2px;
}

/* TABLE OF CONTENTS */
.toc-box {
 background: transparent;
 border: none;
 border-radius: 0;
 padding: 0;
 margin-bottom: 40px;
}

.toc-label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 color: #6b7280;
 font-weight: 700;
 margin-bottom: 16px;
 display: block;
}

.toc-list {
 list-style: none;
 display: grid;
 grid-template-columns: repeat(auto-fit, minmax(200px, 1fr));
 gap: 8px;
}

.toc-list li a {
 display: flex;
 align-items: center;
 gap: 10px;
 padding: 10px 14px;
 background: #f9fafb;
 border: none;
 border-radius: 8px;
 text-decoration: none;
 color: #374151;
 font-size: 14px;
 font-weight: 500;
 transition: all 0.2s;
}

.toc-list li a:hover {
 background: #f3f4f6;
 color: #722F37;
 transform: translateX(4px);
}

.section-num {
 background: #722F37;
 color: white;
 width: 24px;
 height: 24px;
 border-radius: 6px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 11px;
 font-weight: 700;
 flex-shrink: 0;
}

/* WELCOME BOX */
.welcome-box {
 background: linear-gradient(135deg, #fefbf3 0%, #f8f5f0 100%);
 padding: 28px;
 margin-bottom: 40px;
 border-radius: 16px;
 border-left: 5px solid #B8860B;
 box-shadow: 0 4px 12px rgba(0, 0, 0, 0.04);
}

.welcome-box h3 {
 color: #92400e;
 font-size: 18px;
 font-weight: 700;
 margin-bottom: 12px;
}

/* OBJECTIVES BOX */
.objectives-box {
 background: linear-gradient(135deg, #faf5ff 0%, #f3e8ff 100%);
 border-radius: 16px;
 padding: 28px;
 margin-bottom: 40px;
 border: 1px solid #e9d5ff;
}

.box-label {
 font-weight: 700;
 color: #7e22ce;
 text-transform: uppercase;
 letter-spacing: 1px;
 font-size: 12px;
 margin-bottom: 16px;
 display: block;
}

.objectives-box ul {
 list-style: none;
 margin: 0;
 padding: 0;
}

.objectives-box li {
 padding: 10px 0 10px 32px;
 position: relative;
 font-size: 16px;
 color: #4c1d95;
 border-bottom: 1px solid rgba(167, 139, 250, 0.2);
}

.objectives-box li::before {
 content: '‚úì';
 position: absolute;
 left: 0;
 color: #7c3aed;
 font-weight: 700;
}

/* HIGHLIGHT */
.highlight {
 background: linear-gradient(120deg, #fef3c7 0%, #fef3c7 100%);
 padding: 1px 6px;
 border-radius: 4px;
 font-weight: 600;
 color: inherit;
}

/* TYPOGRAPHY */
h2 {
 color: #722F37;
 font-size: 28px;
 margin: 56px 0 24px 0;
 font-weight: 800;
 position: relative;
 padding-bottom: 16px;
}

h2::after {
 content: '';
 position: absolute;
 bottom: 0;
 left: 0;
 width: 60px;
 height: 4px;
 background: linear-gradient(90deg, #B8860B, #D4A813);
 border-radius: 2px;
}

h3 {
 color: #722F37;
 font-size: 22px;
 margin: 36px 0 16px 0;
 font-weight: 700;
}

p {
 font-size: 17px;
 line-height: 1.85;
 color: #374151;
 margin-bottom: 20px;
}

/* CASE STUDY */
.case-study {
 background: white;
 border-radius: 20px;
 margin: 40px 0;
 border: 1px solid #e5e7eb;
 box-shadow: 0 8px 30px rgba(0, 0, 0, 0.06);
 overflow: hidden;
}

.case-study-header {
 background: linear-gradient(90deg, #722F37, #722F37);
 padding: 20px 28px;
 display: flex;
 align-items: center;
 gap: 16px;
}

.case-study-icon {
 width: 48px;
 height: 48px;
 background: rgba(255, 255, 255, 0.2);
 border-radius: 12px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 24px;
}

.case-study-header .title {
 color: white;
 font-weight: 700;
 font-size: 16px;
 margin: 0;
}

.case-study-content {
 padding: 28px;
}

/* TABLES */
.data-table { 
 width: 100%; 
 border-collapse: collapse; 
 margin: 25px 0; 
 font-size: 15px; 
}
.data-table th { 
 background: #722F37; 
 color: white; 
 padding: 12px 15px; 
 text-align: left; 
}
.data-table td { 
 padding: 12px 15px; 
 border-bottom: 1px solid #e5e7eb; 
}
.data-table tr:nth-child(even) { 
 background: #f9fafb; 
}

/* COACH TIP */
.coach-tip {
 background: linear-gradient(135deg, #fefce8 0%, #fef9c3 100%);
 border: 1px solid #fde047;
 border-radius: 16px;
 padding: 24px 28px;
 margin: 32px 0;
 position: relative;
}

.coach-tip .tip-label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 color: #a16207;
 font-weight: 700;
 margin-bottom: 8px;
 display: block;
}

/* MODULE CONNECTION */
.module-connection {
 background: linear-gradient(135deg, #f0f9ff 0%, #e0f2fe 100%);
 border: 1px solid #7dd3fc;
 border-radius: 16px;
 padding: 20px 24px;
 margin-bottom: 32px;
 display: flex;
 align-items: center;
 gap: 16px;
}

/* CHECK YOUR UNDERSTANDING */
.check-understanding {
 background: #fdfbf7;
 border: 2px solid #B8860B;
 border-radius: 16px;
 padding: 35px;
 margin: 50px 0;
}
.check-understanding .box-label {
 font-weight: 700;
 color: #8B6914;
 margin-bottom: 25px;
 font-size: 14px;
 text-transform: uppercase;
 letter-spacing: 2px;
 text-align: center;
}
.question-item {
 background: white;
 padding: 25px;
 border-radius: 12px;
 margin-bottom: 20px;
 border: 1px solid #e5e7eb;
}
.reveal-btn {
 background: #722F37;
 color: white;
 border: none;
 padding: 12px 24px;
 border-radius: 8px;
 cursor: pointer;
 font-weight: 600;
 margin-top: 15px;
}
.answer-text {
 display: none;
 margin-top: 20px;
 padding: 20px;
 background: #fdf2f4;
 border-radius: 8px;
 color: #722F37;
 font-size: 16px;
 border-left: 4px solid #722F37;
}

/* KEY TAKEAWAYS */
.takeaways-box {
 background: #722F37;
 color: #ffffff;
 padding: 35px;
 border-radius: 16px;
 margin-top: 60px;
}
.takeaways-box .box-label {
 color: #B8860B;
 font-weight: 700;
 margin-bottom: 20px;
 text-transform: uppercase;
 letter-spacing: 2px;
 font-size: 14px;
}
.takeaways-box ul {
 margin: 0;
 padding-left: 20px;
}
.takeaways-box li {
 margin-bottom: 12px;
 color: #ffffff;
}

/* REFERENCES */
.references-box {
 background: linear-gradient(135deg, #f8fafc 0%, #f1f5f9 100%);
 border: 1px solid #e2e8f0;
 border-radius: 16px;
 padding: 28px 32px;
 margin-top: 48px;
}
.references-box .box-label {
 color: #64748b;
 font-size: 12px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 font-weight: 700;
 margin-bottom: 16px;
}
.references-box ol {
 padding-left: 20px;
}
.references-box li {
 font-size: 14px;
 color: #475569;
 margin-bottom: 8px;
}

@media (max-width: 768px) {
 .lesson-wrapper { padding: 20px 15px; }
 .lesson-title { font-size: 28px; }
 .toc-list { grid-template-columns: 1fr; }
}
 </style>
</head>
<body>

<div class="lesson-wrapper">
 <!-- Module Header Card -->
 <div class="module-header-card">
 <span class="module-label">Module 12: Complex Co-morbidities and Life-Stage Management</span>
 <h1 class="lesson-title">Advanced Pharmacotherapy and Nutraceutical Interactions</h1>
 <div class="lesson-meta">
 <span class="meta-badge">Lesson 7 of 8</span>
 <span class="meta-badge">‚è±Ô∏è 14 min read</span>
 <span class="meta-badge">Level: Advanced Specialist</span>
 </div>
 </div>

 <!-- ASI Credential Strip -->
 <div class="asi-credential-strip">
 <div class="asi-logo">ASI</div>
 <div class="asi-text">
 <div class="label">Verified Excellence</div>
 <div class="title">AccrediPro Standards Institute‚Ñ¢ Certified Content</div>
 </div>
 </div>

 <!-- Table of Contents -->
 <nav class="toc-box">
 <p class="box-label">Lesson Navigation</p>
 <ul class="toc-list">
 <li><a href="#metformin-berberine"><span class="section-num">01</span>Metformin vs. Berberine</a></li>
 <li><a href="#glp1-agonists"><span class="section-num">02</span>The GLP-1 Revolution</a></li>
 <li><a href="#inositol-precision"><span class="section-num">03</span>Inositol Isoform Ratios</a></li>
 <li><a href="#spiro-ocp"><span class="section-num">04</span>Spironolactone & OCPs</a></li>
 <li><a href="#integrative-monitoring"><span class="section-num">05</span>Integrative Monitoring</a></li>
 </ul>
 </nav>

 <!-- Module Connection -->
 <div class="module-connection">
 <div class="connection-text">
 <p><strong>Building Your Clinical Toolkit:</strong> In previous lessons, we explored the physiological shifts of pregnancy and menopause. Now, we bridge the gap between <em>medical management</em> and <em>integrative support</em>, ensuring you can navigate the complex world of client medications without overstepping your scope.</p>
 </div>
 </div>

 <!-- Welcome Box -->
 <div class="welcome-box">
 <h3>The Biochemical Bridge</h3>
 <p>As a PCOS & Metabolic Health Specialist, you will frequently work with clients who are already prescribed pharmaceuticals. Your role isn't to diagnose or prescribe, but to understand how these agents interact with <strong>The S.T.E.A.D.Y. Method‚Ñ¢</strong>. This lesson provides the deep-dive expertise needed to support clients on Metformin, GLP-1s, and anti-androgens while optimizing their nutraceutical foundation.</p>
 </div>

 <!-- Learning Objectives -->
 <div class="objectives-box">
 <p class="box-label">Learning Objectives</p>
 <ul>
 <li>Compare the biochemical mechanisms of Metformin and Berberine, including nutrient depletion risks.</li>
 <li>Analyze the clinical role of GLP-1 agonists in PCOS and their impact on body composition.</li>
 <li>Differentiate between Myo- and D-Chiro Inositol ratios for specific clinical phenotypes.</li>
 <li>Evaluate the metabolic side effects of Spironolactone and Oral Contraceptive Pills (OCPs).</li>
 <li>Develop a monitoring strategy for lifestyle interventions in medicated clients.</li>
 </ul>
 </div>

 <h2 id="metformin-berberine">The AMPK Duel: Metformin vs. Berberine</h2>
 <p>For decades, Metformin has been the first-line pharmaceutical for insulin-resistant PCOS. However, the botanical alkaloid <span class="highlight">Berberine</span> has emerged as a formidable integrative alternative. Both target the <strong>AMP-activated protein kinase (AMPK)</strong> pathway, often called the body's "metabolic master switch."</p>

 <div class="coach-tip">
 <span class="tip-label">Coach Tip: The B12 Warning</span>
 <p>üí° Long-term Metformin use is clinically associated with a <strong>10-30% reduction</strong> in Vitamin B12 absorption. If a client on Metformin reports unexplained fatigue or tingling (paresthesia), encourage them to request a serum B12 and Methylmalonic Acid (MMA) test from their physician.</p>
 </div>

 <table class="data-table">
 <thead>
 <tr>
 <th>Feature</th>
 <th>Metformin (Pharmaceutical)</th>
 <th>Berberine (Nutraceutical)</th>
 </tr>
 </thead>
 <tbody>
 <tr>
 <td><strong>Primary Mechanism</strong></td>
 <td>Inhibits hepatic gluconeogenesis; activates AMPK.</td>
 <td>Activates AMPK; upregulates LDL receptors; modulates gut microbiota.</td>
 </tr>
 <tr>
 <td><strong>GI Side Effects</strong></td>
 <td>High (Diarrhea, nausea, bloating).</td>
 <td>Moderate (Constipation or diarrhea).</td>
 </tr>
 <tr>
 <td><strong>Nutrient Depletion</strong></td>
 <td><strong>Vitamin B12</strong> and Folate.</td>
 <td>Minimal known depletions.</td>
 </tr>
 <tr>
 <td><strong>Lipid Impact</strong></td>
 <td>Mild improvement in LDL.</td>
 <td>Significant reduction in LDL and Triglycerides.</td>
 </tr>
 </tbody>
 </table>

 <p>While Metformin is excellent for hepatic insulin sensitivity, Berberine offers additional benefits for the <strong>lipid profile</strong> and <strong>gut-hormone axis</strong>. A 2022 meta-analysis found that Berberine was comparable to Metformin in reducing insulin resistance in PCOS patients but superior in reducing waist-to-hip ratios.</p>

 <h2 id="glp1-agonists">The GLP-1 Revolution: Beyond Weight Loss</h2>
 <p>The emergence of GLP-1 (Glucagon-Like Peptide-1) receptor agonists like <strong>Semaglutide</strong> (Ozempic/Wegovy) and <strong>Tirzepatide</strong> (Mounjaro/Zepbound) has shifted the PCOS landscape. These medications mimic incretin hormones that stimulate insulin secretion, inhibit glucagon, and slow gastric emptying.</p>

 <h3>Metabolic Considerations for the Specialist</h3>
 <p>In PCOS, GLP-1s address the profound "incretin defect" often seen in hyperinsulinemic phenotypes. However, for our target demographic (women 40-55), these drugs carry a specific risk: <span class="highlight">Sarcopenic Obesity</span>. Rapid weight loss without adequate protein and resistance training can lead to a disproportionate loss of lean muscle mass, which is detrimental to long-term metabolic rate.</p>

 <div class="case-study">
 <div class="case-study-header">
 <div class="case-study-icon">üë©‚Äçüíº</div>
 <div>
 <p class="title">Case Study: The GLP-1 Muscle Crisis</p>
 <p class="subtitle">Client: Susan, Age 49, Career Transitioner</p>
 </div>
 </div>
 <div class="case-study-content">
 <p><strong>Presenting:</strong> Susan lost 35 lbs in 4 months on Semaglutide. Despite the weight loss, she reported extreme fatigue and "feeling weak" when lifting her grocery bags.</p>
 <p><strong>Intervention:</strong> Using the <strong>A: Activity</strong> pillar of the S.T.E.A.D.Y. Method‚Ñ¢, we shifted her from steady-state cardio to 3 days of progressive resistance training and increased her protein intake to 1.4g/kg of body weight.</p>
 <p><strong>Outcome:</strong> Susan's strength returned, her "skinny fat" appearance improved, and she maintained her metabolic rate even as her medication dose plateaued. Her income as a new wellness coach increased as she shared her "Muscle-First GLP-1" journey with her community.</p>
 </div>
 </div>

 <h2 id="inositol-precision">Inositol Precision: The 40:1 Golden Ratio</h2>
 <p>Inositols are carbocyclic sugars that act as second messengers for insulin signaling. In the ovaries of healthy women, the ratio of <strong>Myo-Inositol (MI)</strong> to <strong>D-Chiro Inositol (DCI)</strong> is approximately 40:1. In women with PCOS, this ratio is often severely skewed.</p>

 <p><strong>The "DCI Paradox":</strong> While DCI is helpful for peripheral insulin sensitivity (muscles and liver), high doses of DCI alone can be toxic to oocytes (eggs) and may worsen androgen production in the ovaries. This is why the 40:1 ratio is considered the "Gold Standard" for PCOS management, particularly for those desiring fertility or cycle regularity.</p>

 <div class="coach-tip">
 <span class="tip-label">Coach Tip: Dosing for Success</span>
 <p>üí° The clinical dose used in most successful trials is <strong>2,000mg Myo-Inositol + 50mg D-Chiro Inositol</strong>, taken twice daily. If a client is only taking Myo-inositol and not seeing results after 3 months, the addition of the small DCI component can often "unlock" their insulin sensitivity.</p>
 </div>

 <h2 id="spiro-ocp">Spironolactone and OCPs: The Metabolic Trade-off</h2>
 <p>Conventional medicine often relies on <strong>Spironolactone</strong> (an anti-androgen) and <strong>Oral Contraceptive Pills (OCPs)</strong> to manage PCOS symptoms like acne and hirsutism. While effective for cosmetic goals, these carry metabolic "hidden costs" that specialists must monitor.</p>

 <ul>
 <li><strong>Spironolactone:</strong> A potassium-sparing diuretic. It can lead to dehydration and electrolyte imbalances. It also has a mild "feminizing" effect on metabolism, which can occasionally increase subcutaneous fat storage.</li>
 <li><strong>OCPs:</strong> While they regulate the bleed, they can increase <strong>Sex Hormone Binding Globulin (SHBG)</strong>, which lowers free testosterone but may also induce insulin resistance and increase C-Reactive Protein (CRP), a marker of systemic inflammation.</li>
 </ul>

 <div class="coach-tip">
 <span class="tip-label">Coach Tip: The Micronutrient Gap</span>
 <p>üí° OCPs are known "nutrient robbers," depleting the body of Magnesium, Zinc, Vitamin C, and B vitamins. When a client is on the pill, the <strong>D: Detoxification</strong> pillar of the S.T.E.A.D.Y. Method‚Ñ¢ becomes even more critical to support liver clearance of synthetic hormones.</p>
 </div>

 <h2 id="integrative-monitoring">Integrative Monitoring: The Specialist's Protocol</h2>
 <p>How do you adjust lifestyle interventions when a client is on multiple agents? We use <strong>The S.T.E.A.D.Y. Method‚Ñ¢</strong> as a dynamic feedback loop.</p>

 <p><strong>1. Glucose Tuning (T):</strong> If a client is on Metformin + Berberine, their risk of hypoglycemia (low blood sugar) increases if they also implement strict Intermittent Fasting. Monitor for dizziness or "hangry" episodes.</p>
 <p><strong>2. Muscle Activation (A):</strong> As discussed, GLP-1 users require a mandatory "Muscle-First" approach to prevent metabolic slowdown.</p>
 <p><strong>3. Detoxification (D):</strong> Clients on Spironolactone or OCPs need extra hydration and cruciferous vegetables (DIM/Sulforaphane) to support the liver's phase II conjugation pathways.</p>

 <div class="check-understanding">
 <p class="box-label">Check Your Understanding</p>
 
 <div class="question-item">
 <p class="question-text"><strong>1. Why is the 40:1 ratio of Myo to D-Chiro Inositol preferred over high-dose D-Chiro Inositol alone?</strong></p>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">High-dose D-Chiro Inositol (DCI) alone can be detrimental to egg quality and may actually increase ovarian androgen production, whereas the 40:1 ratio mimics the physiological environment of a healthy ovary.</div>
 </div>

 <div class="question-item">
 <p class="question-text"><strong>2. What is the primary nutrient depletion risk associated with long-term Metformin use?</strong></p>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">Vitamin B12. Metformin interferes with the absorption of B12 in the ileum, which can lead to fatigue, anemia, and neurological symptoms.</div>
 </div>

 <div class="question-item">
 <p class="question-text"><strong>3. Which medication class carries a high risk of "Sarcopenic Obesity" if not paired with resistance training?</strong></p>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">GLP-1 Agonists (like Semaglutide). The rapid weight loss can include significant muscle tissue loss unless protein intake and resistance training are prioritized.</div>
 </div>

 <div class="question-item">
 <p class="question-text"><strong>4. How do Oral Contraceptive Pills (OCPs) impact systemic inflammation?</strong></p>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">OCPs can increase C-Reactive Protein (CRP), a marker of systemic inflammation, and may also worsen insulin resistance in some phenotypes.</div>
 </div>
 </div>

 <div class="takeaways-box">
 <p class="box-label">Key Takeaways</p>
 <ul>
 <li><strong>Berberine is a "Metformin-Plus":</strong> It offers similar insulin benefits with superior lipid and gut microbiome modulation.</li>
 <li><strong>Muscle is the GLP-1 Insurance Policy:</strong> Specialists must prioritize resistance training for any client on incretin mimetics.</li>
 <li><strong>Inositol Ratios Matter:</strong> Always check labels to ensure clients aren't taking excessive D-Chiro Inositol, which can hinder fertility goals.</li>
 <li><strong>Nutrient Depletion is Real:</strong> Pharmaceuticals like Metformin and OCPs create "micronutrient gaps" that must be filled via targeted nutrition and supplementation.</li>
 </ul>
 </div>

 <div class="references-box">
 <p class="box-label">References & Further Reading</p>
 <ol>
 <li>Rondanelli, M., et al. (2022). "Berberine versus Metformin in women with PCOS: A systematic review and meta-analysis." <em>Nutrients</em>.</li>
 <li>Unluhizarci, K., et al. (2023). "The impact of GLP-1 analogues on metabolic parameters in PCOS: A clinical update." <em>Journal of Endocrinology</em>.</li>
 <li>Nordio, M., et al. (2019). "The 40:1 myo-inositol/D-chiro-inositol plasma ratio is able to restore ovulation in PCOS patients." <em>European Review for Medical and Pharmacological Sciences</em>.</li>
 <li>Palmery, M., et al. (2013). "Oral contraceptives and changes in nutritional requirements." <em>European Review for Medical and Pharmacological Sciences</em>.</li>
 <li>Aroda, V. R., et al. (2016). "Long-term Metformin Use and Vitamin B12 Deficiency in the Diabetes Prevention Program Outcomes Study." <em>The Journal of Clinical Endocrinology & Metabolism</em>.</li>
 </ol>
 </div>
</div>

<script>
 document.querySelectorAll('.reveal-btn').forEach(button => {
 button.addEventListener('click', function() {
 const answer = this.nextElementSibling;
 if (answer && answer.classList.contains('answer-text')) {
 answer.classList.toggle('show');
 answer.style.display = answer.style.display === 'none' || answer.style.display === '' ? 'block' : 'none';
 }
 });
 });
</script>
</body>
</html>